Table 1 Baseline characteristics for study participants
From: Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study
Characteristic | All patients (n = 182) |
|---|---|
Age (years) | 65.1 ± 9.4 |
Male sex | 135 (74.2) |
Smoker | 139 (76.4) |
Hypertension | 67 (36.8) |
Antihypertensive medication | 51 (28.0) |
 Calcium channel blockers | 35 (19.2) |
 RAS inhibitors | 31 (17.0) |
 Others | 14 (7.7) |
Diabetes | 25 (13.7) |
Cardiovascular disease | 10 (5.5) |
Cancer types | |
 Esophagus | 82 (45.1) |
 Head and neck | 77 (42.3) |
 Stomach | 23 (12.6) |
Combined anticancer drugs | 138 (75.8) |
 5-FU | 108 (59.3) |
 TS-1 | 19 (10.4) |
 DOC | 14 (7.7) |
 CPT-11 | 5 (2.7) |
 Capecitabine | 5 (2.7) |